Boviso Animal Health Private Limited
Kanchan Bagh, Indore, Madhya Pradesh
GST No. 23AAQCS5295N1ZI
TrustSEAL Verified
Call 0804897386042% Response Rate
SEND EMAIL
Product Details:
| Minimum Order Quantity | 1 Vial |
| Usage | Clinical |
| Indication | Mastitis |
| Type Of Medicines | Allopathic |
| Grade Standard | Medicine Grade |
| Dosage Form | Parenteral |
| Shelf Life | 2 Years |
| Pack Type | 2 Vial Pack |
| Application | Mastitis Medicine |
| Dose/Strength | 750 mg Cefquinome Sulphate |
| Animal Type | Cow,Buffalo |
| Dosage | 1-2 mg/kg body weight by Intramuscular or Subcutaneous Route |
| Brand | BOVINOME |
| Strength (Milligram) | 750 mg Cefquinome Sulphate |
| Composition | Each vial (Part A) contains Cefquinome as sulphate equivalent to Cefquinome 750 mg |
| Drug | Cefquinome Sulphate |
Description:
BOVINOME is a Cefquinome Sulphate antibiotic which is an extended spectrum Beta-Lactam antibiotic and member of the Fourth Generation Cephalosporins. It is an Amino Thiazole Cephalosporin which have safe and well tolerated in veterinary medicine.
Composition:
Each vial (Part A) contains: Cefquinome as sulphate equivalent to Cefquinome 750 mg
Part B contains: N-Methyl-2 pyrrolidone 300 mg
Indication:
Mammary Infections: Streptococcal Mastitis, Coliform Mastitis, Staphylococcal Mastitis
Respiratory Infections: Haemorrhagic Septicaemia (H.S.) & Contagious Bovine Pleuro Pneumonia (CBPP), Bronchopneumonia, Bovine Respiratory Diseases (BRD)
Gastro Intestinal Tract Infections: Bacterial diarrhoea or dysentery caused by E.coli, Salmonella, Shigella, Campylobacter, Clostridium etc.
Dosage & Administration:
1-2 mg/kg body weight by Intramuscular or Subcutaneous Route
Commercial Presentation:
Cefquinome Sulphate 750 mg & N-Methyl-2-pyrrolidone 300 mg
(20 ml syringe and needle provided with this pack)